Quality of life in children suffering from headaches: a systematic literature review

Ombashi, S.; Tsangaris, E.; Heeres, A. G.; van Roey, V.; Neuteboom, R. F.; van Veelen-Vincent, M. L. C.; Jansson, K.; Mathijssen, I. M. J.; Klassen, A. F.; Versnel, S. L.

doi:10.1186/s10194-023-01595-0

The Journal of Headache and Pain

Table 2 Characteristics of included studies

From: Quality of life in children suffering from headaches: a systematic literature review

Author	Year	Country	Type of headache	Diagnosic criteria	Gender (%) Female-male	Age range (in years)	Sample size	Comparison sample	QoL questionnaire used	Patient-, parent or both reported	Exclusion psychiatric comorbidities
Al-Hashel [21]	2020	Kuwait	PH	ICHD-III crit	69–31	7 to 17	466	N/A	HARDSHIP	Patient	No
Açıkel [22]	2021	Turkey	TTH, M	ICHD-II	42–58	8 to 18	59	Normative sample	HARDSHIP	Patient	Yes
Amouroux [23]	2017	France	M, TTH	ICHD-II crit	43–58	4 to 18	73	N/A	VSP-A	Patient	No
Bai [24]	2017	Netherlands	M, SH	Parent reported	57–43	4 to 11	77	Normative sample, asthma, eczema, ADHD, dyslexia	CHQ-PF28	Parent	Yes
Benore [25]	2018	USA	CM, cTTH, daily headache	ICHD-II crit	74–26	up to 18	135	N/A	PedsQL	Both	No
Bruijn [26]	2009	Netherlands	M, cTTH	IHS class	NR	4 to 17	70	Normative sample, ADHD, asthma	CHQ-PF50	Parent	No
Caruso [27]	2022	USA	M, UdH	ICHD-III, or clinician-reported	76–24	10 to 17	88	N/A	PedsQL	Patient	No
Castro [12]	2013	Brazil	M, cDH, cTTH, eTTH	Episode > 3 months	61–40	7 to 14	185	Normative sample	PedsQL	Patient	No
Chen [28]	2007	Japan	NR	Episode > 6 months	NR	5 to 18	85	Normative sample	PedsQL	Both	Yes
Connelly [29]	2006	USA	M, CDH, eTTH	Neurologist	NR	7 to 12	40	Normative sample	PedsQL	Both	Yes
Cordova [30]b	2021	Germany	RH	Self-reported	37–63	11 to 17	2238	Normative sample	KINDL	Both	No
Gozubatik [31]	2021	Turkey	TTH, M	ICHD-III crit	39–61	8 to 18	61	Normative sample	PedsQL	Patient	Yes
De Tommaso [32]	2017	Italy	M	ICHD-III crit	56–44	8 to 15	151	N/A	PedsQL	Both	No
Dudeney [33]	2019	USA	cH	24 > episodes < 3 months	71–29	10 to 18	56	N/A	PedsQL-SF	Patient	No
Eren [34]	2021	Turkey	M	IHS class	65–35	8 to 18	43	Normative sample	PedsQL	Parent	Yes
Ferracini [35]	2013	Brazil	M	IHS class	NR	6 to 12	50	Normative sample	PedsQL	Both	No
Genc [36]	2021	Lithuania	M, TTH, pMOH, headache ≥ 15 days	Self-reported, ICHD-III crit	-	7 to 17	1858	Normative sample	HARDSHIP	Patient	No
Genizi [37]	2019	Israel	M	ICHD-III crit	59–41	8 to 12	54	Normative sample	PedsQL	Patient	No
Gerber [38]	2010	Germany	M, TTH	IHS class	65–35	7 to 16	34	N/A	KINDL	Both	No
Hainsworth [39]	2014	USA	M, CDH	Episode > 3 months	43–57	11 to 16	7	N/A	PedsQL	Both	No
Hao [40]	2010	China	M	Clinician-reported	50–50	5 to 18	618	Normative sample, leukemia, epilepsy, Gilles de la Tourette's syndrome	PedsQL	Both	No
Hesse [41]	2015	USA	RH	≥ 4 episodes/month for ≥ 3 months	100 (F)	11 to 16	15	N/A	PedsQL	Both	Yes
Kashikar-Zuck [42]	2013	USA	cM	ICHD-II crit	82–18	10 to 18	153	Juvenile fibromyalgia	PedsQL	Both	No
Kernick [43]	2009	UK	NR	Self-reported	NR	12 to 15	648	Normative sample	PedsQL, PedMIDAS	Patient	No
Koenig [44]	2013	Germany	M, CM, eTTH, cTTH	ICHD-II crit	78–22	12 to 17	71	N/A	KIDSCREEN-27	Patient	Yes
Kovacevic [45]	2017	Serbia	M	ICHD-III crit	53–47	7 to 17	32	N/A	KIDSCREEN-27	Both	Yes
Koller [46]	2019	Austria	M	ICHD-III crit	49–51	8 to 17	37	Normative sample	PedsQL	Patient	No
Krause [47]	2016	Germany	NR	Self-reported	NR	3 to 17	10.667	Normative sample	KIDSCREEN-10	Patient	No
Ladner [48]	2016	USA	NR	NR	NR	5 to 18	67	Normative sample	CHIP, HUI3	Both	No
Langeveld [49]	1999	The Netherlands	M	Clinician-reported	60–40	12 to 18	64	Normative sample	QLH-Y	Patient	No
Long [50]	2007	USA	M, TTH or Combined	NR	NR	8 to 10	44	Sickle cell disease, juvenile idiopathic arthritis	CHQ-PF50	Parent	No
Massey [51]	2008	Netherlands	NR	Self-reported	47–53	12 to 18	685	Normative sample	PedsQL-SF	Patient	No
McDonald [8]	2011	USA	M	ICHD-II crit	59–41	12 to 17	531	N/A	MSQ-A	Patient	No
Milde-Busch [52]	2010	Germany	M, TTH	IHS class	61–39	13 to 17	475	Normative sample	KINDL	Patient	No
Nodari [53]	2002	Italy	M, TTH	NR	55–45	10 to 18	310	Normative sample	QLH-Y	Patient	No
Orr [54]	2017	Canada	M	ICHD-II crit	68–32	10 to 18	85	Normative sample	PedsQL	Patient	Yes
Öztop [55]	2016	Turkey	M	IHS class	74–26	9 to 16	35	Normative sample	PedsQL	Both	No
Palermo [56]	2005	USA	M, TTH	NR	NR	13 to 16	45	Sickle cell disease, juvenile idiopathic arthritis	CHQ-CF87	Patient	No
Paniccia [57]	2020	Canada	UdH, M	NR	NR	8 to 12	231	Normative sample	KIDSCREEN-10 Index	NR	No
Petersen [58]	2009	Sweden	NR	Self-reported	NR	8 to 14	769	Normative sample	PedsQL	Both	No
Philipp [59]	2019	Austria	M, TTH, pMOH, UdH, headache ≥ 15 days/month	ICHD-III crit	60–40	10 to 18	2563	Normative sample	KIDSCREEN-10, -52 and -27	NR	No
Powers [60]	2003	USA	M, CDH	IHS class	55–45	2 to 18	572	Normative sample, cancer, rheumatologic disease	PedsQL	Both	No
Powers [61]	2004	USA	M	IHS class	57–43	2 to 18	686	Normative sample	PedsQL	Both	No
Rapoff [62]	2014	USA	M	ICHD-II crit	71–29	7 to 12	35	N/A	PedsQL	Both	Yes
Rettig [63]	2021	USA	CM	Treatment was indicated	21–79	10 to 17	135	N/A	PedsQL	NR	No
Riatha [64]	2013	Indonesia	PH	ICHD-II crit	60–40	13 to 17	75	Normative sample	PedsQL	Patient	No
Rocha-Filho [65]	2014	Brazil	PM, M, TTH, UdH	Clinician-reported	NR	10 to 15	NR	N/A	PedsQL	Patient	No
Sciruicchio [66]	2019	Italy	M, cM	ICHD-II crit	60–41	8 to 17	190	N/A	PedsQL	Both	Yes
Seeger [67]	2014	Canada	PTH	NR	67–33	13 to 17	15	N/A	PedsQL	Patient	No
Şentürk [68]	2022	Turkey	M, TTH, or both	ICHD-III crit	69–31	8 to 18	80	N/A	PedsQL	NR	No
Shaygan [69]	2021	Iran	cH	ICD-II crit	NR	12 to 18	NR	Musculoskeletal pain, other chronic pain	PedsQL	Patient	Yes
Shiri [70]	2013	Israel	M, cTTH	ICHD-II crit	30–70	10 to 18	10	N/A	PedsQL	Patient	Yes
Slater [71]	2012	USA	cDH	ICHD-II crit	78–22	10 to 17	169	N/A	PedsQL	Both	No
Talarska [72]	2017	Poland	M, CH, TTH	IHD-2004	59–41	8 to 18	173	Normative sample, epilepsy	PedsQL	Both	Yes
Talarska [73]	2007	Poland	M, TTH	NR	NR	8 to 18	64	N/A	PedsQL	Both	No
Todorov [74]	2009	USA	M	IHS class	75–25	11 to 17	63	Normative sample	PedsQL, PedMIDAS, MSQ-A	Both	Yes
Uneri [75]	2009	Turkey	M	ICHD-II crit	80–20	13 to 18	30	Normative sample	PedsQL	Both	Yes
Ung [76]	2018	USA	NR	NR	NR	7 to 17	84	N/A	PedsQL	Both	No
Witt [77]	2009	Germany	NR	NR	55–45	7 to 16	67	N/A	KINDL	Patient	No
Wober-Bingol [78]	2014	Austria, Turkey	M, MOH, TTH	ICHD-II crit	52–48	6 to 17	1.073	N/A	HARDSHIP	Patient	No
Yaghini [79]	2022	Iran	M	IHS class	36–64	5 to 15	72	N/A	PedMIDAS	Patient	No

PH Primary Headache, (c)DH (chronic) Daily Headache, cH Chronic Headache, (p)MOH probable Medication Overuse Headache, (c/e)M (chronic/episodic) Migraine, (c/e) TTH (chronic/episodic) Tension Type Headache, RH Recurrent Headaches, UdH undifferentiated headache, NR Not Reported, N/A Not Applicable

Back to article page

ISSN: 1129-2377

Contact us

Submission enquiries: journalsubmissions@springernature.com